Involvement of Matrix Metalloproteinases in Human Immunodeficiency Virus Type 1–Induced Replication by ClinicalMycobacterium aviumIsolates
Author(s) -
Charlene S. Dezzutti,
W. Edward Swords,
Patricia C. Guenthner,
Donna R. Sasso,
Larry M. Wahl,
Alan H. Drummond,
G W Newman,
C. Harold King,
Frederick D. Quinn,
Renu B. Lal
Publication year - 1999
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/314992
Subject(s) - biology , virology , viral replication , matrix metalloproteinase , virus , microbiology and biotechnology , in vitro , serotype , protease , mycobacterium , enzyme , bacteria , genetics , biochemistry
The role of Mycobacterium avium isolates in modulating human immunodeficiency virus type 1 (HIV-1) replication was examined by use of an in vitro, resting T cell system. Two human clinical isolates (serotypes 1 and 4) but not an environmental M. avium isolate (serotype 2) enhanced HIV-1 replication. The M. avium-induced HIV-1 replication was not associated with cell activation or differential cytokine production or utilization. Addition of matrix metalloproteinase (MMP) inhibitors and their in vivo regulators, tissue inhibitors of metalloproteinases-1 and -2, abrogated M. avium-induced HIV-1 replication 80%-95%. The MMP inhibitors did not have any effect on the HIV-1 protease activity, suggesting that they may affect cellular processes. Furthermore, MMP-9 protein was differentially expressed after infection with clinical M. avium isolates and paralleled HIV-1 p24 production. Collectively, these data suggest that M. avium-induced HIV-1 replication is mediated, in part, through the induction of MMP-9.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom